Skip to main content
. 2022 Apr 20;25(5):720–727. doi: 10.1089/jpm.2021.0187

Table 1.

Patient Demographics

Baseline demographic data All pancreatic patients (n = 42) Experimental arm (n = 26) Control arm (n = 16)
Treatment arm, n (%)
 Experimental 26 (61.9) 26 (100.0) 0 (0.0)
 Control 16 (38.1) 0 (0.0) 16 (100.0)
Age, mean (range) 61.8 (21.0–83.0) 60.0 (21.0–83.0) 64.7 (44.0–78.0)
Gender, n (%)
 Female 18 (42.9) 11 (42.3) 7 (43.8)
 Male 24 (57.1) 15 (57.7) 9 (56.3)
Race/Ethnicity, n (%)
 African American 5 (11.9) 3 (11.5) 2 (12.5)
 Asian 5 (11.9) 4 (15.4) 1 (6.3)
 Caucasian 28 (66.7) 16 (61.5) 12 (75.0)
 Hispanic Latino 1 (2.4) 1 (3.8) 0 (0.0)
 Native Hawaiian 1 (2.4) 1 (3.8) 0 (0.0)
 Mixed race 2 (4.8) 1 (3.8) 1 (6.3)
Education, n (%)
 Did not complete high school 1 (2.4) 1 (3.8) 0 (0.0)
 High school 9 (21.4) 4 (15.4) 5 (31.3)
 College 20 (47.6) 12 (46.2) 8 (50.0)
 Graduate/professional school 11 (26.2) 8 (30.8) 3 (18.8)
 Unknown 1 (2.4) 1 (3.8) 0 (0.0)
Religion, n (%)
 None 9 (21.4) 5 (19.2) 4 (25.0)
 Catholic 8 (19.0) 6 (23.1) 2 (12.5)
 Jewish 1 (2.4) 0 (0.0) 1 (6.3)
 Protestant 20 (47.6) 12 (46.2) 8 (50.0)
 Other 4 (9.5) 3 (11.5) 1 (6.3)
Marital status, n (%)
 Never married 3 (7.1) 3 (11.5) 0 (0.0)
 Widowed 4 (9.5) 2 (7.7) 2 (12.5)
 Divorced/separated 1 (2.4) 1 (3.8) 0 (0.0)
 Married/living with partner 34 (81.0) 20 (76.9) 14 (87.5)
Employment status, n (%)
 Employed full time 7 (16.7) 7 (26.9) 0 (0.0)
 Employed part time 4 (9.5) 1 (3.8) 3 (18.8)
 Homemaker 3 (7.1) 2 (7.7) 1 (6.3)
 Retired 23 (54.8) 12 (46.2) 11 (68.8)
 Unemployed 5 (11.9) 4 (15.4) 1 (6.3)
Family income, n (%)
 $10,001–$20,000 1 (2.4) 1 (3.8) 0 (0.0)
 $20,001–$30,000 2 (4.8) 2 (7.7) 0 (0.0)
 $30,001–$40,000 5 (11.9) 3 (11.5) 2 (12.5)
 $40,001–$50,000 4 (9.5) 3 (11.5) 1 (6.2)
 Greater than $50,000 29 (69.0) 16 (61.5) 13 (81.2)
 Unknown 1 (2.4) 1 (3.8) 0 (0.0)
Current or previous surgical procedure, n (%) 18 (42.9) 11 (42.3) 7 (43.8)
Current or previous chemotherapy, n (%) 32 (76.2) 18 (69.2) 14 (87.5)
Current or previous radiation therapy, n (%) 12 (28.6) 8 (30.8) 4 (25.0)
Tried alternative therapies, n (%) 9 (21.4) 5 (19.2) 4 (25.0)
Number of comorbidities, median (range) 1.5 (0–6) 1 (0–6) 2 (2–5)